$EQC
Equity Commonwealth

2024 Q2 Form 10-Q Financial Statement

#000080364924000039 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $14.11M $15.19M
YoY Change -3.3% -2.48%
Cost Of Revenue $6.721M $6.534M
YoY Change -3.18% -9.95%
Gross Profit $7.388M $8.656M
YoY Change -3.4% 4.04%
Gross Profit Margin 52.36% 56.98%
Selling, General & Admin $8.356M $8.323M
YoY Change -39.69% -2.71%
% of Gross Profit 113.1% 96.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.182M $3.626M
YoY Change 9.36% -15.87%
% of Gross Profit 56.61% 41.89%
Operating Expenses $12.54M $12.68M
YoY Change -31.74% -1.44%
Operating Profit -$5.150M -$4.024M
YoY Change -51.96% -11.46%
Interest Expense $29.77M $29.51M
YoY Change 8.84% 4.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $24.62M $25.49M
YoY Change 48.03% 6.95%
Income Tax $434.0K $30.00K
% Of Pretax Income 1.76% 0.12%
Net Earnings $24.15M $23.41M
YoY Change 75.17% 3.19%
Net Earnings / Revenue 171.17% 154.1%
Basic Earnings Per Share
Diluted Earnings Per Share $0.20 $0.22
COMMON SHARES
Basic Shares Outstanding 107.3M shares 107.0M shares
Diluted Shares Outstanding 108.8M shares 108.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.196B $2.171B
YoY Change 1.99% 1.98%
Cash & Equivalents $2.200B $2.171B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $17.26M $16.59M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.213B $2.187B
YoY Change 2.02% 2.01%
LONG-TERM ASSETS
Property, Plant & Equipment $234.3M $235.3M
YoY Change -0.26% -0.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $250.7M $252.3M
YoY Change -0.79% -1.09%
TOTAL ASSETS
Total Short-Term Assets $2.213B $2.187B
Total Long-Term Assets $250.7M $252.3M
Total Assets $2.464B $2.440B
YoY Change 1.73% 1.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.59M $20.83M
YoY Change -2.15% 6.06%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.25M $24.19M
YoY Change -13.52% -11.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.706M $2.166M
YoY Change -13.6% -23.06%
Total Long-Term Liabilities $2.706M $2.166M
YoY Change -13.6% -23.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.25M $24.19M
Total Long-Term Liabilities $2.706M $2.166M
Total Liabilities $25.95M $31.33M
YoY Change -31.46% 3.58%
SHAREHOLDERS EQUITY
Retained Earnings $3.977B $3.952B
YoY Change 2.64% 2.43%
Common Stock $3.941B $3.937B
YoY Change -1.13% -1.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.434B $2.408B
YoY Change
Total Liabilities & Shareholders Equity $2.464B $2.440B
YoY Change 1.73% 1.68%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $24.15M $23.41M
YoY Change 75.17% 3.19%
Depreciation, Depletion And Amortization $4.182M $3.626M
YoY Change 9.36% -15.87%
Cash From Operating Activities $32.91M $22.44M
YoY Change 16.46% -2.88%
INVESTING ACTIVITIES
Capital Expenditures $5.870M $5.055M
YoY Change 209.27% 330.21%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.870M -$5.055M
YoY Change 209.27% 330.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.047M -7.089M
YoY Change 2.5% -98.51%
NET CHANGE
Cash From Operating Activities 32.91M 22.44M
Cash From Investing Activities -5.870M -5.055M
Cash From Financing Activities -2.047M -7.089M
Net Change In Cash 24.99M 10.30M
YoY Change 2.59% -102.27%
FREE CASH FLOW
Cash From Operating Activities $32.91M $22.44M
Capital Expenditures $5.870M $5.055M
Free Cash Flow $27.04M $17.39M
YoY Change 2.58% -20.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2823732000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22751000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
25458000 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4915196 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4915196 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
106847438 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
106847438 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1297000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1350000 usd
CY2024Q1 us-gaap Revenues
Revenues
15190000 usd
CY2023Q1 us-gaap Revenues
Revenues
15576000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
6534000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7256000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4357000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4310000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8323000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8555000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
19214000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
20121000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
29512000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
28376000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25488000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23831000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1080000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
25458000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22751000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
53000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
66000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
25405000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22685000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1997000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1997000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23408000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20688000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107216000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109720000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108224000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111300000 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.22
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.19
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.19
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
4.25
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2390113000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3056000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2565000 usd
CY2024Q1 eqc Dividends And Other Distributions
DividendsAndOtherDistributions
1752000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 usd
CY2024Q1 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2413328000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3395000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
25458000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22751000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
3626000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
3719000 usd
CY2024Q1 us-gaap Straight Line Rent
StraightLineRent
223000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
-279000 usd
CY2024Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
731000 usd
CY2023Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
591000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2565000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2988000 usd
CY2024Q1 eqc Increase Decrease In Rents Receivable And Other Assets
IncreaseDecreaseInRentsReceivableAndOtherAssets
793000 usd
CY2023Q1 eqc Increase Decrease In Rents Receivable And Other Assets
IncreaseDecreaseInRentsReceivableAndOtherAssets
662000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9097000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7018000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
176000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
460000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22443000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23108000 usd
CY2024Q1 eqc Cash Paid For Real Estate Improvements
CashPaidForRealEstateImprovements
5055000 usd
CY2023Q1 eqc Cash Paid For Real Estate Improvements
CashPaidForRealEstateImprovements
1175000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5055000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1175000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3056000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3395000 usd
CY2024Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
2036000 usd
CY2023Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
468232000 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1997000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1997000 usd
CY2024Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
0 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1843000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7089000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-475467000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10299000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-453534000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2160535000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2582222000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2170834000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2128688000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-9000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5433000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1710000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3359000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
7795000 usd
CY2024Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
86000 usd
CY2023Q1 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2200000000 usd
CY2024Q1 us-gaap Real Estate Improvements
RealEstateImprovements
7600000 usd
CY2023Q1 us-gaap Real Estate Improvements
RealEstateImprovements
2000000 usd
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
8816000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
9067000 usd
CY2024Q1 us-gaap Variable Lease Income
VariableLeaseIncome
5077000 usd
CY2023Q1 us-gaap Variable Lease Income
VariableLeaseIncome
5159000 usd
CY2024Q1 us-gaap Lease Income
LeaseIncome
13893000 usd
CY2023Q1 us-gaap Lease Income
LeaseIncome
14226000 usd
CY2024Q1 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
2000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Per Share Cash Paid
PreferredStockDividendsPerShareCashPaid
0.40625
CY2024Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.40625
CY2024Q1 eqc Common Stock Conversion Term
CommonStockConversionTerm
P6M
CY2024Q1 eqc Common Stock Basis For Conversion
CommonStockBasisForConversion
1
CY2024Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
30000 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
30000 usd
CY2024Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1050000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1080000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1443865 shares
CY2024Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
25458000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22751000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
53000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
66000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1997000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1997000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23408000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20688000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
25458000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22751000 usd
CY2024Q1 eqc Net Income Loss Attributable To Noncontrolling Interest Diluted
NetIncomeLossAttributableToNoncontrollingInterestDiluted
53000 usd
CY2023Q1 eqc Net Income Loss Attributable To Noncontrolling Interest Diluted
NetIncomeLossAttributableToNoncontrollingInterestDiluted
66000 usd
CY2024Q1 us-gaap Dilutive Securities
DilutiveSecurities
-1997000 usd
CY2023Q1 us-gaap Dilutive Securities
DilutiveSecurities
-1997000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
23408000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
20688000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107216000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109720000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108224000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111300000 shares
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.22
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.19
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.19
CY2024Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0650
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0650
CY2024Q1 eqc Weighted Average Number Of Shares Restricted Stock Units Unvested
WeightedAverageNumberOfSharesRestrictedStockUnitsUnvested
129000 shares
CY2023Q1 eqc Weighted Average Number Of Shares Restricted Stock Units Unvested
WeightedAverageNumberOfSharesRestrictedStockUnitsUnvested
113000 shares
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000803649-24-000039-index-headers.html Edgar Link pending
0000803649-24-000039-index.html Edgar Link pending
0000803649-24-000039.txt Edgar Link pending
0000803649-24-000039-xbrl.zip Edgar Link pending
eqc-20240331.htm Edgar Link pending
eqc-20240331.xsd Edgar Link pending
eqc33124exhibit311.htm Edgar Link pending
eqc33124exhibit312.htm Edgar Link pending
eqc33124exhibit321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
eqc-20240331_def.xml Edgar Link unprocessable
eqc-20240331_lab.xml Edgar Link unprocessable
eqc-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
eqc-20240331_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
eqc-20240331_cal.xml Edgar Link unprocessable